Institut de Cancérologie Strasbourg (ICANS)
Research facility
Location:
Strasbourg,
France (FR)
ROR: https://ror.org/008fdbn61
HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022)
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al.
Conference contribution
A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022)
Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al.
Conference contribution
An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021)
Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al.
Conference contribution